A detailed history of Quest Partners LLC transactions in Vericel Corp stock. As of the latest transaction made, Quest Partners LLC holds 11 shares of VCEL stock, worth $635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 11 -0.0%
Holding current value
$635
Previous $505,000 7.92%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$41.71 - $52.9 $583 - $740
-14 Reduced 56.0%
11 $505,000
Q1 2024

May 09, 2024

BUY
$32.52 - $52.33 $813 - $1,308
25 New
25 $1.3 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.73B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.